Litigation

Recent Posts

McNeil-PPC Enters Consent Decree For Violations At 3 Manufacturing Plants
Posted on 11 Mar 2011 by Tom Moylan

PHILADELPHIA -- (Mealey's) The McNeil-PPC Inc. division of Johnson & Johnson on March 10 entered into a consent decree of permanent injunction with the federal government for manufacturing violations at three plants that resulted in several over... Read More

La. Supreme Court Reverses $330M Verdict For Risperdal Medicaid Law Violations
Posted on 29 Jan 2014 by Tom Moylan

NEW ORLEANS — (Mealey’s) In a 4-3 vote, the Louisiana Supreme Court on Jan. 28 reversed a verdict of more than $330.6 million against Janssen Pharmaceutical Inc. and parent company Johnson & Johnson, finding that the state attorney general... Read More

Johnson & Johnson, DePuy Pay $76.9 Million To Settle Foreign Bribery Claims
Posted on 12 Apr 2011 by Tom Moylan

(Mealey's) Johnson & Johnson (J&J) and subsidiary DePuy International Ltd. will pay $76.9 million to resolve criminal and civil allegations in the United States and in the United Kingdom that they paid kickbacks to doctors in Greece, Poland... Read More

Pennsylvania Jury Awards $10 Million To Girl In Children's Motrin Case
Posted on 20 May 2011 by Tom Moylan

PHILADELPHIA - (Mealey's) A Pennsylvania state court jury on May 20 awarded $10 million in compensatory damages to a 13-year-old girl who claims that she suffered extensive burns and was blinded in one eye by Children's Motrin when she was 3-1... Read More

U.S. High Court Won’t Decide ‘Clear Evidence’ In $63 Million Children’s Motrin Verdict
Posted on 19 Jan 2016 by Tom Moylan

WASHINGTON, D.C. — (Mealey's) The U.S. Supreme Court on Jan. 19 denied a petition by Johnson & Johnson and a subsidiary to decide if denial of a citizen petition constitutes “clear evidence” that the Food and Drug Administration... Read More

Pa. High Court: Drug Company Lacks Standing To Challenge State’s Outside Counsel
Posted on 18 Aug 2010 by Tom Moylan

PHILADELPHIA - (Mealey's) Janssen Pharmaceutica Inc. lacks standing under Pennsylvania law to challenge the hiring of outside counsel to represent the state in a Risperdal off-label marketing lawsuit, the Pennsylvania Supreme Court ruled Aug. 17 ... Read More

California Appeals Court Affirms Children's Motrin Defense Verdict
Posted on 21 Oct 2010 by Tom Moylan

LOS ANGELES -- A California state appeals court on Oct. 20 affirmed a defense verdict in a Children's Motrin case, saying that the trial judge properly excluded an exhibit that was irrelevant and did not err by failing to give the jury a "heeding... Read More

Pennsylvania State Court Jury Awards $2.5 Million In Risperdal Gynecomastia Trial
Posted on 24 Feb 2015 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Feb. 24 awarded $2.5 million to the family of a man who claimed that the atypical antipsychotic drug Risperdal caused gynecomastia, or enlarged male breasts ( P.P., et al. v. Ortho... Read More

McNeil Pleads Guilty, Pays $25M For Making Adulterated Children’s Medicines
Posted on 11 Mar 2015 by Tom Moylan

PHILADELPHIA — (Mealey’s) The McNeil-PPC Inc. subsidiary of Johnson & Johnson on March 10 pleaded guilty to a federal misdemeanor criminal charge of making adulterated children’s over-the-counter medicines and agreed to pay a criminal... Read More

Johnson & Johnson, 2 Units Plead Guilty, Pay $2.2 Billion In Criminal, Civil Penalties
Posted on 4 Nov 2013 by Tom Moylan

WASHINGTON, D.C. — (Mealey’s) Two Johnson & Johnson subsidiaries have pleaded guilty, and the parent company and two subsidiaries will pay $2.2 billion in criminal fines, civil penalties and forfeitures in one criminal and several civil... Read More